Core Viewpoint - The company is preparing for a significant transition by proposing the issuance of H shares and listing on the Hong Kong Stock Exchange, which aims to enhance its global presence and diversify financing channels [4][5][10]. Board Meeting Details - The second session of the company's board meeting was held on August 13, 2025, with all nine directors present, confirming compliance with relevant laws and regulations [1]. - The board unanimously approved several key proposals, including the election of new board members and the cancellation of the supervisory board [2][3][4]. Board Elections - The board proposed candidates for the third board of directors, including both non-independent and independent directors, with terms set for three years upon shareholder approval [2][3]. - The candidates for non-independent directors include Cheng Zhuo, Fang Lin, Zhao Lingyun, Zhou Chijun, and Liu Feng, while independent director candidates are Zhong Qi, Zhou Yana, and Wang Lede [2][3]. Cancellation of Supervisory Board - The board approved the cancellation of the supervisory board, which is expected to improve the governance structure and align with current legal requirements [4][3]. H Share Issuance - The company plans to issue H shares to enhance its international brand image and competitiveness, with the issuance expected to account for approximately 15% of the total share capital post-issuance [5][10]. - The issuance will be conducted through public offerings in Hong Kong and international placements, with specific details to be determined based on market conditions [9][12]. Use of Proceeds - Proceeds from the H share issuance will be allocated to capacity expansion, product development, market expansion, strategic investments, and general corporate purposes [18][19]. Governance and Compliance - The board approved revisions to the company's articles of association and internal governance systems to comply with Hong Kong regulations and support the H share issuance [20][22]. - The company will appoint Ernst & Young as the auditing firm for the H share issuance, ensuring compliance with relevant financial regulations [27]. Upcoming Shareholder Meeting - A shareholder meeting is scheduled for August 29, 2025, to review and approve the proposals discussed in the board meeting [30].

证券代码：688432 证券简称：有研硅 公告编号：2025-026 有研半导体硅材料股份公司 关于取消监事会、修订《公司章程》、制定和修订 部分公司治理制度的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 有研半导体硅材料股份公司（以下简称"公司"）于 2025 年 8 月 12 日召开 第二届董事会第十次会议审议通过了《关于公司取消监事会、修订 <公司章程> 并办理工商变更登记的议案》 《关于制定和修订部分公司治理制度的议案》，现将 相关情况公告如下： 一、取消公司监事会并修订《公司章程》及相关制度的原因及依据 为进一步完善公司治理结构，促进公司规范运作，根据《中华人民共和国公 司法》《上市公司章程指引（2025 年修订）》《上海证券交易所科创板股票上 市规则（2025 年 4 月修订）》等法律法规及规范性文件的规定，结合公司实际 情况，公司将不再设置监事会和监事，监事会的职权由董事会审计委员会行使。 《有研半导体硅材料股份公司监事会议事规则》等监事会相关制度相应废止。同 时《有研半导体硅材料股份公司章程》（以下 ...

证券代码：600961 证券简称：株冶集团 公告编号：2025-024 株洲冶炼集团股份有限公司 关于修订《公司章程》并取消监事会的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 为进一步完善公司治理结构，促进上市公司规范运作，根据《公司法》《上 市公司章程指引》 《上市公司独立董事管理办法》 《上市公司股东会规则》等相关 法律法规及规范性文件的规定，结合本公司实际情况，2025 年 8 月 12 日公司召 开第八届董事会第十二次会议审议通过了《关于修订 <公司章程> 的议案》，拟对 《公司章程》部分条款进行修订。 本次《公司章程》修订经公司股东大会审议通过后，公司将不再设置监事会、 监事，监事会的职权由董事会审计委员会行使，公司《监事会议事规则》相应废 止。 《公司章程》具体修订内容如下： 修改前 修改后 第一条 为维护株洲冶炼集团股份 第一条 为维护株洲冶炼集团股份 有限公司、股东和债权人的合法权益， 有限公司、股东、职工和债权人的合法 规范株洲冶炼集团股份有限公司的行 权益，规范株洲冶炼集团股份有限公司 为准则，坚 ...

济南高新发展股份有限公司 网络投票时间：采用上海证券交易所股东大会网络投票系统，通过交易系统 投票平台的投票时间为股东大会召开当日的交易时间段，即9:15—9:25,9:30— 现场会议地点：中国（山东）自由贸易试验区济南片区经十东路7000号汉峪 金融商务中心A4-4号楼11层1123室 会议召集人：公司董事会 会议议程： 二〇二五年第三次临时股东大会 会 议 资 料 二〇二五年八月 济高发展（600807） 2025 年第三次临时股东大会 现场会议召开时间：2025年8月18日 上午9点15分； 济高发展（600807） 2025 年第三次临时股东大会 议案一 一、主持人宣布代表资格审查结果； 二、宣读"会议须知"； 三、审议并讨论议案： 四、股东或股东授权代表投票表决： 五、计票； 六、主持人宣布股东大会现场部分结束。 关于审议修订《公司章程》并取消监事会的议案 各位股东： 为进一步完善公司治理结构，提高公司规范运作水平，保护投资者合法权益， 根据《中华人民共和国公司法》、中国证监会《关于新 <公司法> 配套制度规则实 施相关过渡期安排》《上市公司章程指引（2025年修订）》《上市公司治理准则》 等法律 ...

Core Viewpoint - Shanghai Jinghua Adhesive New Materials Co., Ltd. has decided to abolish its supervisory board and amend its articles of association and certain management systems to enhance corporate governance and compliance with relevant laws and regulations [1][2]. Summary by Sections Cancellation of Supervisory Board - The company will no longer have a supervisory board, with the audit committee of the board of directors assuming the powers previously held by the supervisory board as per the Company Law and relevant regulations [1]. Amendments to Articles of Association - The amendments aim to further standardize company operations and improve governance in accordance with the latest legal requirements [2]. - Key changes include: - The first article now emphasizes the protection of the rights of shareholders, employees, and creditors [2]. - The second article clarifies the company's registration and legal status [2]. - The eighth article states that the chairman of the board is the legal representative of the company [2]. - The ninth article outlines the responsibilities of the legal representative and the company's liability for civil activities conducted in its name [2]. - The tenth article specifies that the company's assets are divided into equal shares, with shareholders liable only to the extent of their subscribed shares [2]. - The articles now include provisions for the issuance and transfer of shares, ensuring equal treatment for all shareholders [2][4].

Group 1 - The latest stock price of the company is 18.93 yuan, which represents an increase of 0.37% compared to the previous trading day [1] - The stock reached a maximum of 18.93 yuan and a minimum of 18.74 yuan during the trading session, with a trading volume of 28,000 hands and a transaction amount of 53 million yuan [1] - The company operates in the automotive parts industry, focusing on the research, development, production, and sales of connector products for automotive electronics and consumer electronics [1] Group 2 - The company is headquartered in Zhejiang and its products are widely used in fields such as new energy vehicles [1] - A recent announcement indicated that the company held a workers' representative meeting to elect Tang Ronghua as the employee director and to supplement him as a member of the board's remuneration and assessment committee, which will enhance the company's governance structure [1] Group 3 - On the day of the report, the net inflow of main funds was 1.0636 million yuan, but there was a cumulative net outflow of 6.3245 million yuan over the past five trading days [1]

Core Points - The Shanghai Cathay Biotech Co., Ltd. is holding its second extraordinary general meeting of shareholders in 2025 on August 18 [1][2] - The meeting aims to ensure the legal rights of all shareholders and maintain order and efficiency during the proceedings [2][3] Meeting Procedures - Shareholders must verify their identity upon arrival and sign in to confirm their attendance [2][3] - Attendees are required to return their shareholder certificates and meeting folders after the meeting [3] - Shareholders have the right to speak and vote during the meeting, but must adhere to the agenda and obtain permission from the meeting host to speak [3][5] Voting and Agenda - The network voting will take place on August 18, 2025, during specified trading hours [5] - The agenda includes the announcement of the meeting's commencement, introduction of attendees, and the review of several proposals [9] - Key proposals include the cancellation of the supervisory board and amendments to the company's articles of association [5][8] Proposals Overview - Proposal 1: Cancellation of the supervisory board and modification of the company's articles to enhance governance structure [5][6] - Proposal 2: Amendments to the company's rules for shareholder meetings and other governance documents to ensure compliance with relevant laws [8] - Proposal 3: Election of non-independent directors for the third board, with candidates nominated for a three-year term [11][12] - Proposal 4: Election of independent directors for the third board, with candidates already approved by the Shanghai Stock Exchange [11][12]

Overall Revision Summary - The company has revised its Articles of Association to enhance governance structure and compliance with the updated Company Law and relevant regulations [1][2] - The company will abolish the supervisory board and its rules, transferring its responsibilities to the Audit and Risk Control Committee of the board [2][3] Key Amendments to Articles of Association - The term "Shareholders' Meeting" has been standardized to "Shareholders' Assembly," and new sections regarding controlling shareholders, independent directors, and board committees have been added [2][3] - The company will no longer have a supervisory board, and the current supervisors will cease their roles, with the Audit and Risk Control Committee assuming the supervisory functions [2][3] - The revised Articles emphasize the importance of legal compliance and governance, aligning with the principles of the Communist Party of China [4][5] Governance and Management Structure - The Articles outline the responsibilities of the board of directors as the legal representatives of the company, including the appointment of a new legal representative within 30 days if the current one resigns [3][4] - The company aims to strengthen its legal governance and compliance management, ensuring the protection of the rights of shareholders and creditors [4][5] Company Mission and Values - The company’s mission is to enhance the quality of life through technological advancement and integrity, focusing on high-quality development and maximizing shareholder value [6][7] - The company is committed to becoming a trusted global provider of pharmaceutical and medical device services, contributing to national health initiatives and the Belt and Road Initiative [6][7] Shareholder Rights and Responsibilities - Shareholders have the right to receive dividends and participate in decision-making processes, including the right to request meetings and propose agenda items [12][13] - The company emphasizes the obligation of shareholders to comply with laws and regulations, ensuring responsible exercise of their rights [18][19] Financial and Operational Governance - The company will implement strict regulations regarding external guarantees, requiring shareholder approval for guarantees exceeding certain thresholds [25][26] - The Articles stipulate that the company must maintain transparency in its financial dealings and adhere to regulatory requirements for information disclosure [26][27]

本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 中科微至科技股份有限公司（以下简称"公司"）于 2025 年 8 月 8 日召开第 二届董事会第二十五次会议审议通过了《关于修订 <中科微至科技股份有限公司> 章程>、新增及修订公司部分治理制度的议案》、《关于增选第二届董事会非独 立董事的议案》，现将有关情况公告如下： 一、本次增加董事会人数的情况说明 二、增选第二届董事会非独立董事的情况说明 证券代码：688211 证券简称：中科微至 公告编号：2025-036 中科微至科技股份有限公司 关于增选第二届董事会非独立董事的公告 根据《中华人民共和国公司法》（以下简称"《公司法》"）《上市公司章程 指引》等法律法规、规范性文件的规定，结合公司实际情况，为进一步完善公司 治理结构，切实保障公司长期战略规划的有效实施，公司拟修订《中科微至科技 股份有限公司章程》，将董事会成员由 7 名增至 9 名，新增一名非独立董事，一 名职工代表董事，独立董事保持 3 名不变。职工代表董事由职工代表大会选举产 生。 附件：非独立董事候选人简历 ...

杭叉集团股东大会会议资料 杭叉集团股份有限公司 会议资料 中国·杭州 二○二五年八月 杭叉集团股东大会会议资料 议案三： 关于公司增加为客户提供融资租赁业务回购担保额度的议案 ........ 79 杭叉集团股东大会会议资料 会议议程 一、会议时间 现场会议：2025 年 8 月 13 日（星期三）14:00 网络投票：2025 年 8 月 13 日（星期三）采用上海证券交易所网络投票系统，通过 交易系统投票平台的投票时间为股东大会召开当日的交易时间段，即 9:15-9:25， 二、现场会议地点 浙江省杭州市临安区相府路 666 号公司办公楼一楼 8 号会议室 三、会议主持人 杭叉集团股份有限公司董事长赵礼敏先生 四、会议审议事项 五、会议流程 (一) 会议开始 (二) 宣读议案 (三) 审议议案并投票表决 占公司有表决权股份总数的比例 杭叉集团股东大会会议资料 事及相关与会人员在股东大会会议记录上签字 (四) 会议决议 (五) 会议主持人宣布闭会 杭叉集团股东大会会议资料 会议须知 为了维护杭叉集团股份有限公司（以下简称"公司"或"杭叉集团"）全体股 东的合法权益，确保股东大会的正常秩序和议事效率，保证大会 ...